Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Northeast Arkansas Clinic
Jonesboro, Arkansas, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Watson Clinic Center for Cancer Care and Research
Lakeland, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Graves-Gilbert Clinic
Bowling Green, Kentucky, United States
- Consultants in Blood Disorders and Cancer
Louisville, Kentucky, United States
- Hematology Oncology Life Center
Alexandria, Louisiana, United States
- Mercy Hospital
Portland, Maine, United States
- Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- Montana Cancer Institute Foundation
Missoula, Montana, United States
- Oncology Hematology Care
Cincinnati, Ohio, United States
- Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States
- Associates in Hematology Oncology
Chattanooga, Tennessee, United States
- Family Cancer Center
Collierville, Tennessee, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- 30 Apr 2009
- Completion
- 30 Nov 2009
- Last update posted
- 31 Jan 2013
- Registered enrollment
- 61
- Registry id
- NCT00305942
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.